Loading...
OTCM
ONWRF
Market cap138mUSD
May 19, Last price  
4.60USD
1D
-4.76%
IPO
-27.56%
Name

ONWARD Medical NV

Chart & Performance

D1W1MN
P/E
—
P/S
231.16
EPS
—
Div Yield, %
—
Shrs. gr., 5y
7.70%
Rev. gr., 5y
2.34%
Revenues
532k
-75.23%
474,000554,000800,0001,399,0002,148,000532,000
Net income
-36m
L+10.40%
-9,912,000-13,483,000-20,014,000-34,314,000-32,772,000-36,181,000
CFO
-32m
L+20.93%
-7,156,000-9,845,000-12,901,000-19,874,000-26,685,000-32,270,000

Profile

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARCEX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer, which restores or enhances physical movement of hand and arm function to people with spinal cord therapy; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord that enables long-paralyzed people to stand and walk again with little or no assistance. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of ARCEX Therapy in restoring strength and function of upper extremities in people with spinal cord injury. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
URL
https://www.onwd.com/
IPO date
Oct 21, 2021
Employees
96
Domiciled in
NL
Incorporated in
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
532
-75.23%
2,148
53.54%
Cost of revenue
43,461
37,848
Unusual Expense (Income)
NOPBT
(42,929)
(35,700)
NOPBT Margin
Operating Taxes
107
(766)
Tax Rate
NOPAT
(43,036)
(34,934)
Net income
(36,181)
10.40%
(32,772)
-4.49%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
568
427
Long-term debt
17,925
15,671
Deferred revenue
Other long-term liabilities
2,081
1,121
Net debt
(11,275)
(57,916)
Cash flow
Cash from operating activities
(32,270)
(26,685)
CAPEX
(422)
(417)
Cash from investing activities
19,578
(20,417)
Cash from financing activities
813
(557)
FCF
(43,032)
(34,650)
Balance
Cash
29,768
61,760
Long term investments
12,254
Excess cash
29,741
73,907
Stockholders' equity
(137,318)
(102,618)
Invested Capital
174,204
170,062
ROIC
ROCE
EV
Common stock shares outstanding
30,184
30,184
Price
Market cap
EV
EBITDA
(42,203)
(34,965)
EV/EBITDA
Interest
600
1,515
Interest/NOPBT